Maximus vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi beats Maximus overall, scoring 7.7/10 vs 7.1/10. Maximus is more affordable at $150/mo vs $179/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at Maximus and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Maximus

#45 of 52

7.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Maximus	MEDVi
Our Score	7.1/10	7.7/10
Starting Price	$150/mo	$179/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Men who want GLP-1 alongside testosterone or other men's health protocols	Users who want a low entry price with oral and injectable compounded options
Ranking	#45	#20
Get started	Visit Maximus	Visit MEDVi

Pros & Cons Compared

Maximus

Pros

+Lowest entry price in the market, $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

MEDVi edges out Maximus with a score of 7.7/10 vs 7.1/10. If budget is your priority, Maximus starts at $150/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Maximus nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review